Content area
Full Text
Two years ago, Daniel R Salomon was diagnosed with colon cancer. As the cancer progressed, he steadfastly remained on the same path of life that he had been travelling for many years: he continued his research in immunology and organ transplantation at the Scripps Research Institute in La Jolla, California; he continued to mentor his students, young doctors, and medical researchers; and he continued to spend as much time as possible with his family, and with his extended family of colleagues and friends.
In 2016 Salomon was the co-author of 16 research papers, including a key paper published in March, that showed that acute and chronic kidney rejection, previously thought to be separate diseases, are instead different parts of the same immune rejection process. 1 "For our transplant population," Salomon said after publication of the paper, "this is a major new understanding of the molecular basis of immune rejection that challenges the field to reconsider its current paradigms and has multiple immediate and actionable therapy implications for patients." 2
In a tribute written after Salomon's death, Kenneth A Newell, a transplant surgeon at Emory University, and past president of the American Society of Transplantation, said that Salomon had a "passion for cutting edge translational science" and that he had made lasting contributions to the field as a clinician, as a mentor, and as a leader of the American Society of Transplantation.
Salomon's research over the years focused on transplantation and immunology, including pioneering work on fundamental molecular mechanisms of...